(Q54627123)

1 June 2018

title

VHL mutations and dysregulation of pVHL- and PTEN-controlled pathways in multilocular cystic renal cell carcinoma. (English)

1 reference

1 June 2018

5

Holger Moch

1 reference

1 June 2018

author name string

Adriana von Teichman

1

1 reference

1 June 2018

Eva Compérat

2

1 reference

1 June 2018

Silvia Behnke

3

1 reference

1 June 2018

Martina Storz

4

1 reference

1 June 2018

Peter Schraml

6

1 reference

1 June 2018

publication date

10 December 2010

1 reference

1 June 2018

published in

Modern Pathology

1 reference

1 June 2018

volume

24

1 reference

1 June 2018

issue

4

1 reference

1 June 2018

page(s)

571-578

1 reference

1 June 2018

https://scigraph.springernature.com/pub.10.1038/modpathol.2010.222

exact match

0 references

cites work

Mining tissue microarray data to uncover combinations of biomarker expression patterns that improve intermediate staging and grading of clear cell renal cell cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

pVHL and PTEN tumour suppressor proteins cooperatively suppress kidney cyst formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

Pax2 gene dosage influences cystogenesis in autosomal dominant polycystic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

pVHL and GSK3beta are components of a primary cilium-maintenance signalling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

The PAX2 tanscription factor is expressed in cystic and hyperproliferative dysplastic epithelia in human kidney malformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

Sporadic clear cell renal cell carcinoma but not the papillary type is characterized by severely reduced frequency of primary cilia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

Cystic renal tumors: new entities and novel concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

Tubulocystic carcinoma of the kidney: clinicopathologic analysis of 31 cases of a distinctive rare subtype of renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

Alterations in VHL as potential biomarkers in renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

Mutations of the VHL tumour suppressor gene in renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

Diverse effects of mutations in exon II of the von Hippel-Lindau (VHL) tumor suppressor gene on the interaction of pVHL with the cytosolic chaperonin and pVHL-dependent ubiquitin ligase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

Low copy number DNA template can render polymerase chain reaction error prone in a sequence-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

The VHL tumor suppressor: riding tandem with GSK3beta in primary cilium maintenance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

Combined VHLH and PTEN mutation causes genital tract cystadenoma and squamous metaplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

Loss of VHL and hypoxia provokes PAX2 up-regulation in clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

Multilocular cystic renal cell carcinoma is a subtype of clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

7 January 2021

pVHL: a multipurpose adaptor protein

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

7 January 2021

Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

7 January 2021

Multilocular cystic renal cell carcinoma : a report of 45 cases of a kidney tumor of low malignant potential.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

7 January 2021

Epidermal growth factor receptor expression is associated with rapid tumor cell proliferation in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

7 January 2021

EGF-r gene copy number changes in renal cell carcinoma detected by fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

7 January 2021

Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

7 January 2021

Reduced Pax2 gene dosage increases apoptosis and slows the progression of renal cystic disease

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2010.222

7 January 2021

10.1038/MODPATHOL.2010.222

Identifiers

DOI

1 reference

1 June 2018

1 reference

1 June 2018